Description
Supplied as pre-filled pens and ampoules: 10 mg/ml
Antiparkinson Agent
In Canada, Movapo (Apomorphine Hydrochloride Injection, 10 mg/mL) is indicated for the acute, intermittent treatment of hypomobility, “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) in patients with advanced Parkinson’s disease.
2) Movapo Patient Medication Information
3) Communication to patients
4) Communication to organisations
Link to : APO-go PEN 10 mg/mL Solution for injection